Drug companies seek approval to deliver new drug through pre-filled syringes
Progenics Pharmaceuticals Inc. and Wyeth Pharmaceuticals said they have submitted an application to the U.S. Food and Drug Administration and European regulators to approve the use of pre-filled syringes with their Relistor constipation drug. The medication itself has already received regulatory approval.
Progenics, an Eastview-based biotech company, partnered with Wyeth in 2005 to jointly develop and sell Relistor, an injectable drug designed to treat constipation caused by painkillers. If regulators approves the use of the pre-filled syringes, the drug could be available in that form in the United States and Europe by the first half of next year and be easier to administer to patients, according to the companies.